Healthcare is the segment driving the growth of Clinical Mass Spectrometry Market
The clinical mass spectrometry market is witnessing high growth owing to integration of omics technologies such as proteomics, metabolomics and lipidomics with mass spectrometry. Mass spectrometry based omics technologies help in identification of biomarkers for various diseases and thus play an important role in precision medicine approach. Another key trend contributing to the market growth...
0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
Sponsor